Period Ending | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 | Mar 30, 2012 |
---|
Total Revenue
|
1,508,900
|
1,413,900
|
1,491,400
|
1,391,900
| Cost of Revenue | 189,200 | 188,800 | 201,700 | 195,800 | |
Gross Profit
|
1,319,700
|
1,225,100
|
1,289,700
|
1,196,100
| |
|
Operating Expenses |
|
Research Development | 239,300 | 293,300 | 232,000 | 225,000 |
|
Selling General and Administrative | 557,900 | 540,800 | 584,600 | 585,100 |
|
Non Recurring | 23,300 | 3,800 | 900 |
-
|
|
Others | 33,200 | 33,200 | 33,300 | 31,600 |
|
|
|
Total Operating Expenses | 853,700 | 871,100 | 850,800 |
-
| | |
Operating Income or Loss
|
466,000
|
354,000
|
438,900
|
354,400
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (1,900) | (7,300) | 6,600 | (13,800) |
|
Earnings Before Interest And Taxes | 464,100 | 346,700 | 445,500 | 340,600 |
|
Interest Expense | 14,800 | 15,900 | 17,100 | 15,800 |
|
Income Before Tax | 449,300 | 330,800 | 428,400 | 324,800 |
|
Income Tax Expense | 124,100 | 80,200 | 132,000 | 94,500 |
|
Minority Interest | (1,000) | (1,200) | (1,000) | (500) |
|
|
|
Net Income From Continuing Ops | 324,200 | 249,400 | 295,400 | 229,800 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
324,200
|
249,400
|
295,400
|
229,800
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
324,200
|
249,400
|
295,400
|
229,800
|
|